Design, construction and validation of a magnetic particle imaging (MPI) system for human brain imaging.

Magnetic Particle Imaging (MPI) was introduced in 2005 as a promising, tracer-based medical imaging modality with the potential for high sensitivity and spatial resolution. Since then, numerous preclinical devices have been built but only a few human-scale devices, none of which targeted functional neuroimaging. In this work, we probe the challenges of scaling the technology to meet the needs of human functional neuroimaging with sufficient sensitivity for detecting the hemodynamic changes following brain activation with a spatio-temporal resolution comparable to current functional Magnetic Resonance Imaging (fMRI) approaches.

Preclinical and Clinical-Scale Magnetic Particle Imaging of Natural Killer Cells: in vitro and ex vivo Demonstration of Cellular Sensitivity, Resolution, and Quantification.

Purpose: Clinical adoption of NK cell immunotherapy is underway for medulloblastoma and osteosarcoma, however there is currently little feedback on cell fate after administration. We propose magnetic particle imaging (MPI) may have applications for the quantitative detection of NK cells.

Procedures: Human-derived NK-92 cells were labeled by co-incubation with iron oxide nanoparticles (VivoTrax™) for 24 h then excess nanoparticles were washed with centrifugation.

Functional magnetic particle imaging (fMPI) of cerebrovascular changes in the rat brain during hypercapnia.

Non-invasive functional brain imaging modalities are limited in number, each with its own complex trade-offs between sensitivity, spatial and temporal resolution, and the directness with which the measured signals reflect neuronal activation. Magnetic particle imaging (MPI) directly maps the cerebral blood volume (CBV), and its high sensitivity derives from the nonlinear magnetization of the superparamagnetic iron oxide nanoparticle (SPION) tracer confined to the blood pool. Our work evaluates functional MPI (fMPI) as a new hemodynamic functional imaging modality by mapping the CBV response in a rodent model where CBV is modulated by hypercapnic breathing manipulation.

A sensitive, stable, continuously rotating FFL MPI system for functional imaging of the rat brain.

Magnetic particle imaging noninvasively maps the distribution of superparamagnetic iron oxide nanoparticles with high sensitivity. Since the particles are confined to the blood pool within the brain, it may be well-suited for cerebral blood volume (CBV)-based functional neuroimaging with MPI (fMPI). Here, we present a magnetic particle imaging system designed to detect the CBV modulation at the hemodynamic timescale (~5 sec) in rodents.

Concept for using magnetic particle imaging for intraoperative margin analysis in breast-conserving surgery.

Breast-conserving surgery (BCS) is a commonly utilized treatment for early stage breast cancers but has relatively high reexcision rates due to post-surgical identification of positive margins. A fast, specific, sensitive, easy-to-use tool for assessing margins intraoperatively could reduce the need for additional surgeries, and while many techniques have been explored, the clinical need is still unmet. We assess the potential of Magnetic Particle Imaging (MPI) for intraoperative margin assessment in BCS, using a passively or actively tumor-targeted iron oxide agent and two hardware devices: a hand-held Magnetic Particle detector for identifying residual tumor in the breast, and a small-bore MPI scanner for quickly imaging the tumor distribution in the excised specimen.

Rodent Cerebral Blood Volume (CBV) changes during hypercapnia observed using Magnetic Particle Imaging (MPI) detection.

Magnetic Particle Imaging (MPI) is a rapidly developing imaging modality that directly measures and maps the concentration of injected superparamagnetic iron oxide nanoparticles (SPIOs). Since the agent does not cross the blood-brain barrier, cerebral SPIO concentration provides a direct probe of Cerebral Blood Volume (CBV). Here we provide an initial demonstration of the ability of MPI to detect functional CBV changes (fCBV) by monitoring SPIO concentration during hypercapnic manipulation in a rat model.

Design analysis of an MPI human functional brain scanner.

MPI's high sensitivity makes it a promising modality for imaging brain function. Functional contrast is proposed based on blood SPION concentration changes due to Cerebral Blood Volume (CBV) increases during activation, a mechanism utilized in fMRI studies. MPI offers the potential for a direct and more sensitive measure of SPION concentration, and thus CBV, than fMRI.